- Home
- ANGO vs UROY Comparison
ANGO vs UROY Comparison
Compare ANGO & UROY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANGO
- UROY
- Stock Information
- Founded
- ANGO 1988
- UROY 2017
- Country
- ANGO United States
- UROY Canada
- Employees
- ANGO N/A
- UROY N/A
- Industry
- ANGO Medical/Dental Instruments
- UROY
- Sector
- ANGO Health Care
- UROY
- Exchange
- ANGO Nasdaq
- UROY Nasdaq
- Market Cap
- ANGO 279.1M
- UROY 292.6M
- IPO Year
- ANGO 2004
- UROY N/A
- Fundamental
- Price
- ANGO $11.94
- UROY $2.39
- Analyst Decision
- ANGO Strong Buy
- UROY Strong Buy
- Analyst Count
- ANGO 3
- UROY 2
- Target Price
- ANGO $13.00
- UROY $5.60
- AVG Volume (30 Days)
- ANGO 849.3K
- UROY 2.0M
- Earning Date
- ANGO 01-08-2025
- UROY 03-14-2025
- Dividend Yield
- ANGO N/A
- UROY N/A
- EPS Growth
- ANGO N/A
- UROY 256.61
- EPS
- ANGO N/A
- UROY 0.03
- Revenue
- ANGO $286,498,000.00
- UROY $27,478,292.00
- Revenue This Year
- ANGO N/A
- UROY N/A
- Revenue Next Year
- ANGO $7.69
- UROY $34.24
- P/E Ratio
- ANGO N/A
- UROY $87.60
- Revenue Growth
- ANGO N/A
- UROY 31.26
- 52 Week Low
- ANGO $5.26
- UROY $1.86
- 52 Week High
- ANGO $13.13
- UROY $3.76
- Technical
- Relative Strength Index (RSI)
- ANGO 64.64
- UROY 54.77
- Support Level
- ANGO $11.65
- UROY $2.20
- Resistance Level
- ANGO $12.96
- UROY $2.45
- Average True Range (ATR)
- ANGO 0.69
- UROY 0.12
- MACD
- ANGO 0.16
- UROY 0.02
- Stochastic Oscillator
- ANGO 72.83
- UROY 82.28
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
About UROY Uranium Royalty Corp.
Uranium Royalty Corp is focused on gaining exposure to uranium prices by making investments in uranium interests, including royalties, streams, debt and equity investments in uranium companies, and through holdings of physical uranium. The company operates in a single segment that is the investment in a portfolio of uranium interests.